Literature DB >> 30742570

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca, Jeffrey R Garber, W Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B Hirsch, Paul S Jellinger, Janet B McGill, Jeffrey I Mechanick, Paul D Rosenblit, Guillermo E Umpierrez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30742570     DOI: 10.4158/CS-2018-0535

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  108 in total

1.  Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart disease.

Authors:  Yun Shen; Jian Zhou; Lizheng Shi; Elizabeth Nauman; Peter T Katzmarzyk; Eboni G Price-Haywood; Ronald Horswell; San Chu; Shengping Yang; Alessandra N Bazzano; Somesh Nigam; Gang Hu
Journal:  Diabetes Obes Metab       Date:  2020-03-31       Impact factor: 6.577

Review 2.  From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.

Authors:  Ofri Mosenzon; Stefano Del Prato; Meir Schechter; Lawrence A Leiter; Antonio Ceriello; Ralph A DeFronzo; Itamar Raz
Journal:  Cardiovasc Diabetol       Date:  2021-04-28       Impact factor: 9.951

3.  The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.

Authors:  Jung-Im Shin; Yingying Sang; Alex R Chang; Stephan C Dunning; Josef Coresh; Lesley A Inker; Elizabeth Selvin; Shoshana H Ballew; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

Review 4.  Novel therapies with precision mechanisms for type 2 diabetes mellitus.

Authors:  Leigh Perreault; Jay S Skyler; Julio Rosenstock
Journal:  Nat Rev Endocrinol       Date:  2021-05-04       Impact factor: 43.330

Review 5.  Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.

Authors:  Elizabeth M Vaughan; Jaime J Rueda; Susan L Samson; David J Hyman
Journal:  Curr Diabetes Rev       Date:  2020

Review 6.  Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.

Authors:  Jeffrey I Mechanick; Michael E Farkouh; Jonathan D Newman; W Timothy Garvey
Journal:  J Am Coll Cardiol       Date:  2020-02-11       Impact factor: 24.094

7.  Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes.

Authors:  John E Anderson
Journal:  Diabetes Spectr       Date:  2020-05

Review 8.  Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin.

Authors:  Kevin Cowart
Journal:  Clin Diabetes       Date:  2020-07

Review 9.  Type 2 diabetes mellitus in older adults: clinical considerations and management.

Authors:  Srikanth Bellary; Ioannis Kyrou; James E Brown; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2021-06-25       Impact factor: 43.330

10.  Significant effects of Ganoderma lucidum polysaccharide on lipid metabolism in diabetes may be associated with the activation of the FAM3C-HSF1-CAM signaling pathway.

Authors:  Rui Pan; Jian Lou; Ling Wei
Journal:  Exp Ther Med       Date:  2021-06-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.